why choose us

First received: August 21, 2024

Clinical Trial: Adverse Neonatal Outcomes with a Shortened Clinical Regimen of Dexamethasone.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Preterm Birth

Study Type: INTERVENTIONAL


Official Title: Adverse Neonatal Outcomes with a Shortened Clinical Regimen of Dexamethasone: Single-blind Randomized Clinical Trial: UNODEXA Trial

Brief Summary: Respiratory morbidity, including respiratory distress syndrome (RDS), is a serious complication of preterm birth and the leading cause of early neonatal mortality and disability.The effects of antenatal corticosteroid administration on fetal lung maturation have been widely studied in order to counteract such adverse perinatal outcomes of preterm birth.The dexamethasone regimen will be evaluated at different administration frequencies, but at the same total dose.The hypothesis is: The type of dexamethasone regimen…

Read more